Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 603 All time
- Disclosed funding
- $28.7B 480 disclosed amounts
- Median round
- $17M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| RB Revascular Bio Co., Ltd.Company profile Revascular Bio develops cell therapies using vascular endothelial stem cells. Revascular Bio develops cell therapies using vascular endothelial stem cells. | Undisclosed | FY2025 Go-Tech research and development grantUndisclosed | Biotech | Japan | Investors Undisclosed | |
| IB Human intestinal organoids for preclinical research and testing. | $2M | Pre-seed | Biotech | United States | Investors | |
| AB Aoxi BiopharmaceuticalCompany profile Develops antibody–oligonucleotide conjugates to deliver nucleic-acid medicines to disease-related cells. Develops antibody–oligonucleotide conjugates to deliver nucleic-acid medicines to disease-related cells. | CN¥12M | Grant-to-equity project support disclosed May 2025Undisclosed | Biotech | China | Investors Undisclosed | |
| O OmnioCompany profile Omnio develops a plasminogen-based biologic for chronic wounds, initially diabetic foot ulcers. Omnio develops a plasminogen-based biologic for chronic wounds, initially diabetic foot ulcers. | ~€4.3M | Funding roundUndisclosed | Biotech | Sweden | Investors Undisclosed | |
| V VitroscopeCompany profile Vitroscope builds laboratory platforms that keep living tissue under controlled fluid flow for drug discovery and disease research. Vitroscope builds laboratory platforms that keep living tissue under controlled fluid flow for drug discovery and disease research. | ≤NOK 16M | vitro.scale grant approvalUndisclosed | Biotech | Norway | Investors | |
Latigo BiotherapeuticsCompany profile Latigo Biotherapeutics develops non-opioid pain medicines that target peripheral pain signaling. Latigo Biotherapeutics develops non-opioid pain medicines that target peripheral pain signaling. | $150M | Series B | Biotech | United States | Investors | |
| RB Revascular Bio Co., Ltd.Company profile Revascular Bio develops cell therapies using vascular endothelial stem cells. Revascular Bio develops cell therapies using vascular endothelial stem cells. | ¥3M | FY2024 second MU-TECH research grantUndisclosed | Biotech | Japan | Investors | |
| mI molmir Inc.Company profile molmir develops ways to observe molecular dynamics and uses that knowledge to identify new targets for medicines. molmir develops ways to observe molecular dynamics and uses that knowledge to identify new targets for medicines. | ¥3M | FY2024 second MU-TECH research grantUndisclosed | Biotech | Japan | Investors | |
| AT Arctic TherapeuticsCompany profile Arctic Therapeutics develops treatments for neurological, autoimmune and inflammatory skin diseases using insights from human genetics. Arctic Therapeutics develops treatments for neurological, autoimmune and inflammatory skin diseases using insights from human genetics. | €26.5M | Series A | Biotech | Iceland | Investors | |
| O OMGene.AICompany profile Behavioral intelligence combining AI, genomic research and human data to model decisions and simulate outcomes. Behavioral intelligence combining AI, genomic research and human data to model decisions and simulate outcomes. | $3M | Infinity Group research fundingUndisclosed | Biotech, AI | Israel | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Delix Therapeutics, Alethio Therapeutics, Estuary Biotherapeutics
27rounds6led - 2Eli Lilly and Company
Oyster Therapeutics, BigHat Biosciences, Circle Pharma, Inc.
16rounds0led - 3Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
16rounds1led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
16rounds1led - 5OrbiMed
Dren Bio, Star Therapeutics, Leal Therapeutics
12rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.